Now showing items 1-1 of 1
Immunological response in mice bearing LM3 breast tumor undergoing Pulchellin treatment
(BMC Complementary and Alternative Medicine, 2012-07-24) [Artigo]
Background: Ribosome-inactivating proteins (RIP) have been studied in the search for toxins that could be used as immunotoxins for cancer treatment. Pulchellin, a type 2 RIP, is suggested to induce immune responses that ...